Improving Management of Patients at High Risk for Osteoporotic Fractures (0000-038)

NCT ID: NCT00139438

Last Updated: 2016-04-22

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 4266 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2004-09-30
• Study Completion Date: 2005-06-30

Brief Summary

The purpose of this study is to assess the impact of disease management interventions on percent receiving a bone densitometry test and percent appropriately prescribed a medication for osteoporosis.

Conditions

Osteoporosis

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Blinding Strategy: NONE

Interventions

Disease Management Assessment

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Members of the Horizon Blue Cross Blue Shield of New Jersey who are at risk for osteoporosis based on age (women age 65 or older, men and women age 45 or older who have a history of fragility fracture or have a history of taking oral glucocorticoids over 3 months).

• Minimum Eligible Age: 45 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Merck Sharp & Dohme LLC

INDUSTRY

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Daniel H. Solomon, M.D., M.P.H.

Role: PRINCIPAL_INVESTIGATOR

Brigham and Woman's Hospital

Other Identifiers

038

Identifier Type: -

Identifier Source: secondary_id

2005_049

Identifier Type: -

Identifier Source: secondary_id

0000-038

Identifier Type: -

Identifier Source: org_study_id